Biotech

All Articles

Editas profit Tip Cas9 licensing civil liberties for $57M

.Against the backdrop of a Cas9 license war that refuses to pass away, Editas Medicine is actually m...

Ultragenyx modifies genetics treatment application to call up effectiveness

.A minority of clients taking Ultragenyx Drug's Wilson health condition gene therapy UX701 have actu...

Biopharma cutback cost maintains in Q3: Fierce Biotech review

.As summer season heat energy looks to cool down winds, hopes that this year will take widespread bu...

J &amp J drops period 2 dengue candidate in most recent change coming from injections

.Johnson &amp Johnson's deprioritization of its transmittable disease pipeline has actually claimed ...

Relay loses 10% of team after earlier cutbacks in July

.Preciseness medicine biotech Relay Therapies is shedding around 10% of its own staff in initiatives...

Pentixapharm ratings $22M IPO to deposit radiopharma tests

.Pentixapharm has introduced almost 20 thousand euros ($ 22 million) coming from an IPO, along with ...

Lundbeck water faucets Charles Waterway for AI-enabled neuro medicine invention

.Lundbeck has used Charles River Laboratories' artificial intelligence functionalities to aid the di...

Big pharma, biotech 'will not always be cooperative' in AI: S&ampP

.Significant Pharma is putting in highly in AI to slash progression timelines and foster innovation....

I &amp I biotech Triveni elevates $115M for preclinical antibodies

.Triveni Biography has roped in $115 thousand in set B funds to progress preclinical antitoxin cours...

IGM pivots from cancer to autoimmune, shocking C-suite

.IGM Biosciences finished in 2013 laying off staff as well as improving its own cancer cells pipe. C...